What animal models help researchers understand NMOSD pathogenesis?
Researchers use animal models to study how neuromyelitis optica spectrum disorder (NMOSD) develops. These models help uncover the roles of immune cells, antibodies, and inflammation. The most common models involve mice or rats that are immunized with aquaporin-4 (AQP4) protein or given antibodies from patients. No single model perfectly mimics human NMOSD, but together they provide valuable insights.
What the research says
A narrative review of NMOSD animal models describes four key areas: breakdown of immune tolerance, T-cell and B-cell collaboration, antibody-mediated injury, and inflammatory tissue environments 4. Each model targets one or more of these aspects. For example, injecting AQP4 peptide into mice causes retinal and optic nerve damage similar to human NMOSD, including inner retinal dysfunction and blood-retinal barrier breakdown 5. This model helps study how AQP4 antibodies damage the optic nerve.
Other models use passive transfer of patient antibodies or T-cell injections to trigger disease. These models have shown that AQP4 antibodies can cause astrocyte injury and inflammation 4. Preclinical studies also use animal models to test new treatments, such as aquaporin-blocking antibodies 6. A mouse model of mycophenolate mofetil (MMF) gastrointestinal toxicity in NMOSD revealed that gut bacteria play a role in side effects, highlighting how models can address treatment complications 7.
Despite their usefulness, animal models have limitations. Immune tolerance in animals makes it hard to induce strong autoimmune responses like those in humans 4. Therefore, researchers combine different models to get a fuller picture of NMOSD pathogenesis.
What to ask your doctor
- How do animal model findings translate to human NMOSD treatment?
- Are there any animal studies that support the use of my current medication?
- What are the main limitations of animal models for NMOSD?
- Could new treatments tested in animal models become available in clinical trials?
This question is drawn from common patient questions about Neurology and answered using cited medical research. We do not provide individualized advice.